亚洲依依成人综合网站,手机看片国内基地,日本性爱视频大全在线观看,秋水一色性福利导航,欧美A级V片在线观看,韩国论理片,欧美特色AAA大片,6一12泑女WWW,肥臀喷水上位

產品中心

Product center

  1. 首頁 > 小分子化合物 > 信號通路 > 細胞周期 > XMD8-92

XMD8-92 99%

2-[[2-ethoxy-4-(4-hydroxy-1-piperidinyl)phenyl]amino]-5,11-dihydro-5,11-dimethyl-6H-pyrimido[4,5-b][1,4]benzodiazepin-6-one

源葉(MedMol)
S81258
1234480-50-2
C26H30N6O3
474.57
品牌 貨號 產品規格 價格(RMB) 庫存（上海） 北京 武漢 南京 購買數量
源葉(MedMol) S81258-5mg 99% ￥170.00元 10 - - -
源葉(MedMol) S81258-10mg 99% ￥290.00元 10 - - -
源葉(MedMol) S81258-50mg 99% ￥920.00元 2 - - -
源葉(MedMol) S81258-100mg 99% ￥1480.00元 預計交期：2-3天 - - -
產品介紹 參考文獻 質檢證書(COA) 摩爾濃度計算器 相關產品

產品介紹

XMD8-92 is a potent ERK5 (BMK1)/BRD4 inhibitor with Kds of 80 and 190 nM, respectively. XMD8-92 inhibits DCAMKL2, PLK4 and TNK1 with Kds of 190, 600 and 890 nM, respectively. Anti-cancer activity
產品描述： XMD8-92 is a potent ERK5 (BMK1)/BRD4 inhibitor with Kds of 80 and 190 nM, respectively. XMD8-92 inhibits DCAMKL2, PLK4 and TNK1 with Kds of 190, 600 and 890 nM, respectively. Anti-cancer activity
靶點： BMK1:80 nM (Kd);BRD4:190 nM (Kd);ERK;?BMI-1;?EpigeneticReaderDomain
體外研究：
XMD8-92 (0-5 Μm; 48 hours) inhibits the proliferation of HMEC and cancer cells.
XMD8-92 effectively inhibits BMK1 activation as well as induces PML’s (promyelocytic leukemia protein) downstream effector, p21. XMD8-92 significantly inhibits basic fibroblast growth factor (bFGF) induced angiogenesis in Matrigel plugs. XMD8-92 significantly induces p21 expression in HeLa and A549 cells. Cell Viability Assay Cell Line: HMEC, A549 and HeLa cells Concentration: 0.16, 0.32, 0.63, 1.25, 2.5 or 5 μM Incubation Time: 48 hours Result: Inhibited the proliferation of HMEC and cancer cells.
體內研究：
XMD8-92 (i.p.; twice a day for 28 days) significantly inhibits the growth of the xenografted human tumors. Animal Model: HeLa Xenograft Model (6-week-old Nod/Scid mice)[1] Dosage: 50 mg/kg Administration: I.p.; twice a day for 28 days Result: Significantly inhibited the growth of the xenografted human tumors.
參考文獻：
1. Yang Q, et al. Pharmacological inhibition of BMK1 suppresses tumor growth through promyelocytic leukemia protein.Cancer Cell. 2010 Sep 14;18(3):258-67. 2. Yang Q, et al. Targeting the BMK1 MAP kinase pathway in cancer therapy. Clin Cancer Res. 2011 Jun 1;17(11):3527-32. 3. Lin EC, et al. ERK5 kinase activity is dispensable for cellular immune response and proliferation. Proc Natl Acad Sci U S A. 2016;113(42):11865-11870. 4. Umapathy G, et al. The kinase ALK stimulates the kinase ERK5 to promote the expression of the oncogene MYCN in neuroblastoma. Sci Signal. 2014 Oct 28;7(349):ra102.
溶解性： soluble  in  DMSO
保存條件： -20℃
配置溶液濃度參考：
1mg 5mg 10mg
1 mM 2.107 ml 10.536 ml 21.072 ml
5 mM 0.421 ml 2.107 ml 4.214 ml
10 mM 0.211 ml 1.054 ml 2.107 ml
50 mM 0.042 ml 0.211 ml 0.421 ml
注意： 部分產品我司僅能提供部分信息，我司不保證所提供信息的權威性，僅供客戶參考交流研究之用。

參考文獻

質檢證書(COA)

如何獲取質檢證書(COA)?
請輸入貨號和一個與之匹配的批號。
例如:
批號：C10000001 貨號：A800001-25g
在貨品標簽上如何找到貨號和批號?

摩爾濃度計算器

質量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)

=
×
×

相關產品